✦ LIBER ✦

HER2/neu (E75) vaccine reduces breast cancer recurrence

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Longterm Followup Assessment of a HER2/n

✍ Jeremy D. Gates; Mark G. Carmichael; Linda C. Benavides; Jarrod P. Holmes; Matth 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Phase IB trial of the Her2/neu peptide (

✍ E.A. Mittendorf; S. Khoo; Z.A. Dehqanzada; M.T. Hueman; C.E. Storrer; K.A. Harri 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 88 KB

E75 cancer vaccine benefit greater with

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

The GP2 peptide: A HER2/neu-based breast

✍ Kevin S. Clive; Josh A. Tyler; G. Travis Clifton; Jarrod P. Holmes; Sathibalan P 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Comparison of immunological responses in

✍ M. T. Hueman; J. M. Gurney; C. E. Storrer; L. Kotula; K. Jackson; M. Wilson; C. 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 296 KB

Immunoediting breast cancer using HER-2/

✍ B.J. Czerniecki; U. Koldovsky; S. Xu; R. Mick; H. Nisenbaum; S. Orel; K. Fox; P. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB